The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing

References

• ClementiMBarbujaniGTurollaLTenconiRNeurofibromatosis-1: a maximum likelihood estimation of mutation rateHum Genet19908421161182105266
   PubMed Web of Science ®Google Scholar
• EvansDGHowardEGiblinCBirth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register serviceAm J Med Genet A2010152A232733220082463
   PubMed Web of Science ®Google Scholar
• NeurofibromatosisConference statement. National Institutes of Health Consensus Development ConferenceArch Neurol19884555755783128965
   PubMedGoogle Scholar
• González-PérezALópez-BigasNImproving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, CondelAm J Hum Genet201188444044921457909
   PubMed Web of Science ®Google Scholar
• KumarDDisorders of the genome architecture: a reviewGenomic Med200823–4697619277903
   PubMedGoogle Scholar
• AdzhubeiIASchmidtSPeshkinLA method and server for predicting damaging missense mutationsNat Methods20107424824920354512
   PubMed Web of Science ®Google Scholar
• ShihabHAGoughJCooperDNPredicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov modelsHum Mutat2013341576523033316
   PubMed Web of Science ®Google Scholar
• RevaBAntipinYSanderCPredicting the functional impact of protein mutations: application to cancer genomicsNucleic Acids Res20113917e11821727090
   PubMed Web of Science ®Google Scholar
• PemovALiHPatidarRThe primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromasOncogene201736223168317728068329
   PubMed Web of Science ®Google Scholar
• SantoroCGiuglianoTMeloneMABMultiple spinal nerve enlargement and SOS1 mutation: further evidence of overlap between neurofibromatosis type 1 and Noonan phenotypeClin Genet201893113814328456002
   PubMed Web of Science ®Google Scholar
• GallingerSAronsonMShayanKGastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutationGastroenterology2004126257658514762794
   PubMed Web of Science ®Google Scholar
• CawthonRMO’ConnellPBuchbergAMIdentification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcriptsGenomics1990745555652117566
   PubMed Web of Science ®Google Scholar
• De LucaASchirinziABuccinoANovel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1Hum Mutat2004236629
   Web of Science ®Google Scholar
• CastleBBaserMEHusonSMCooperDNUpadhyayaMEvaluation of genotype-phenotype correlations in neurofibromatosis type 1J Med Genet20034010e10914569132
   PubMed Web of Science ®Google Scholar
• SabbaghAPasmantEImbardANF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceHum Mutat201334111510151823913538
   PubMed Web of Science ®Google Scholar
• UpadhyayaMHusonSMDaviesMAn absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlationAm J Hum Genet200780114015117160901
   PubMed Web of Science ®Google Scholar
• PinnaVLanariVDanielePp.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromasEur J Hum Genet20152381068107125370043
   PubMed Web of Science ®Google Scholar
• UpadhyayaMRuggieriMMaynardJGross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delayHum Genet199810255915979654211
   PubMed Web of Science ®Google Scholar
• MautnerVFKluweLFriedrichREClinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletionsJ Med Genet201047962363020543202
   PubMed Web of Science ®Google Scholar
• PasmantESabbaghASpurlockGNF1 microdeletions in neurofibromatosis type 1: from genotype to phenotypeHum Mutat2010316E1506E151820513137
   PubMed Web of Science ®Google Scholar
• MonroeCLDahiyaSGutmannDHDissecting clinical heterogeneity in neurofibromatosis type 1Annu Rev Pathol201712537428135565
   PubMed Web of Science ®Google Scholar
• Diggs-AndrewsKABrownJAGianinoSMRubinJBWozniakDFGutmannDHSex is a major determinant of neuronal dysfunction in neurofibromatosis type 1Ann Neurol201475230931624375753
   PubMed Web of Science ®Google Scholar
• WarringtonNMSunTLuoJThe cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patientsCancer Res2015751162125381154
   PubMed Web of Science ®Google Scholar
• UpadhyayaMCooperDNNeurofibromatosis Type 1: Molecular and Cellular BiologyNew YorkSpringer2013
   Google Scholar
• CareyJCBatyBJJohnsonJPMorrisonTSkolnickMKivlinJThe genetic aspects of neurofibromatosisAnn N Y Acad Sci198648645563105404
   PubMed Web of Science ®Google Scholar
• PasmantESabbaghAMasliah-PlanchonJRole of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1J Natl Cancer Inst2011103221713172222034633
   PubMedGoogle Scholar
• DeBellaKSzudekJFriedmanJMUse of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in childrenPediatrics20001053 pt 160861410699117
   PubMed Web of Science ®Google Scholar
• Laycock-van SpykSThomasNCooperDNUpadhyayaMNeurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesisHum Genomics20115662369022155606
   PubMedGoogle Scholar
• SantDWMargrafRLStevensonDAEvaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1J Med Genet201552425626125612910
   PubMed Web of Science ®Google Scholar
• PaiSGCarneiroBAMotaJMWnt/beta-catenin pathway: modulating anticancer immune responseJ Hematol Oncol201710110128476164
   PubMed Web of Science ®Google Scholar
• NusseRCleversHWnt/beta-catenin signaling, disease, and emerging therapeutic modalitiesCell2017169698599928575679
   PubMed Web of Science ®Google Scholar
• RodgersSJFergusonDTMitchellCAOomsLMRegulation of PI3K effector signalling in cancer by the phosphoinositide phosphatasesBiosci Rep2017371 pii: BSR20160432
   PubMed Web of Science ®Google Scholar
• SteinmannKKluweLFriedrichREMautnerVFCooperDNKehrer-SawatzkiHMechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromasJ Invest Dermatol2009129361562118800150
   PubMed Web of Science ®Google Scholar
• De LucaABernardiniLCeccariniCFluorescence in situ hybridization analysis of allelic losses involving the long arm of chromosome 17 in NF1-associated neurofibromasCancer Genet Cytogenet2004150216817215066327
   PubMedGoogle Scholar